SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ulta Beauty, Inc. (ULTA) trades at a trailing P/E of 21.0, forward P/E of 20.8. Trailing earnings yield is 4.77%, forward earnings yield 4.82%. PEG 17.46. Graham Number is $190.22.
Criteria proven by this page:
- VALUE (71/100, Pass) — P/E is below market average (21.0); analyst target implies upside (+34.1%); earnings yield beats bond yields (4.77%).
- Forward P/E 20.8 (down from trailing 21.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 17.46 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 4.77% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.82% as earnings recover.
- Analyst consensus target $715.07 (+34.1% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
71/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ULTA
Valuation Multiples
P/E (TTM)21.0
Forward P/E20.8
PEG Ratio17.46
Forward PEG103.75
P/B Ratio8.62
P/S Ratio1.93
EV/EBITDA13.9
Per Share Data
EPS (TTM)$25.72
Forward EPS (Est.)$25.69
Book Value / Share$62.52
Revenue / Share$276.37
FCF / Share$21.98
Yields & Fair Value
Earnings Yield4.77%
Forward Earnings Yield4.82%
Dividend Yield0.00%
Graham Number$190.22
SharesGrow IV$769.52 (+44.4%)
Analyst Target$715.07 (+34.1%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2017 |
41.5 |
1.34 |
10.98 |
3.51 |
- |
| 2018 |
24.6 |
0.65 |
7.71 |
2.32 |
- |
| 2019 |
26.5 |
1.21 |
9.60 |
2.60 |
- |
| 2020 |
22.0 |
2.00 |
8.15 |
2.09 |
- |
| 2021 |
90.4 |
-1.21 |
7.95 |
2.59 |
- |
| 2022 |
20.1 |
0.04 |
12.91 |
2.30 |
- |
| 2023 |
21.3 |
0.63 |
13.48 |
2.59 |
- |
| 2024 |
19.2 |
2.31 |
10.86 |
2.21 |
- |
| 2025 |
16.2 |
-5.73 |
7.82 |
1.72 |
- |
| 2026 |
25.2 |
22.87 |
10.35 |
2.34 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$6.52 |
$4.85B |
$409.76M |
8.4% |
| 2017 |
$8.96 |
$5.88B |
$555.23M |
9.4% |
| 2018 |
$10.94 |
$6.72B |
$658.56M |
9.8% |
| 2019 |
$12.15 |
$7.4B |
$705.95M |
9.5% |
| 2020 |
$3.11 |
$6.15B |
$175.84M |
2.9% |
| 2021 |
$17.98 |
$8.63B |
$985.84M |
11.4% |
| 2022 |
$24.01 |
$10.21B |
$1.24B |
12.2% |
| 2023 |
$26.03 |
$11.21B |
$1.29B |
11.5% |
| 2024 |
$25.34 |
$11.3B |
$1.2B |
10.6% |
| 2025 |
$25.64 |
$12.39B |
$1.15B |
9.3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$25.69 |
$25.36 – $26.65 |
$12.33B |
$12.17B – $12.41B |
18 |
| 2027 |
$28.57 |
$27.60 – $29.27 |
$13.22B |
$13.16B – $13.3B |
18 |
| 2028 |
$31.63 |
$31.00 – $33.95 |
$13.96B |
$13.52B – $14.17B |
17 |
| 2029 |
$34.60 |
$32.17 – $35.82 |
$14.68B |
$14.67B – $14.68B |
7 |
| 2030 |
$36.83 |
$36.08 – $37.43 |
$15.09B |
$14.86B – $15.28B |
4 |
